Symbol
| HDAC3
| contributors: mct/ - updated : 10-04-2019
|
HGNC name
| histone deacetylase 3
|
HGNC id
| 4854
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in squamous cell lung carcinomas | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
blood | | | |
HDAC3 inhibitors are being considered as promising candidates for cancer therapy | blood | | | |
promising target for therapies aiming to expand hematopoietic stem cells | neurology | neurodegenerative | | |
HDAC3 inhibitors being tested for relief of expansion-associated gene silencing may also suppress somatic expansions that contribute to disease progression | allergy | | | |
HDAC3 serves as a target for development of allergy therapeutics. |
| | | |
| deletion of Hdac3 or Nr1d1 in mouse liver causes hepatic steatosis |